-
公开(公告)号:US20240228599A1
公开(公告)日:2024-07-11
申请号:US18504416
申请日:2023-11-08
申请人: Genzyme Corporation
CPC分类号: C07K16/18 , C07K16/40 , A61K2039/505 , C07K2317/24 , C07K2317/33 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: The present disclosure provides anti-complement factor Bb antibodies, and compositions comprising the antibodies. The anti-Bb antibodies are useful for treating complement-me-diated disorders. The present disclosure provides methods of treating complement-mediated disorders.